{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:54:16Z","timestamp":1791863656679,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T00:00:00Z","timestamp":1561334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001862","name":"Svenska Forskningsr&amp;#x00E5;det Formas","doi-asserted-by":"publisher","award":["2009-1069"],"award-info":[{"award-number":["2009-1069"]}],"id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Preeclampsia is a major cause of maternal and fetal morbidity. Emerging research shows an association with environmental exposures. The present aim was to investigate associations between early pregnancy serum levels of perfluoroalkyl substances (PFAS) and preeclampsia. Within the Swedish SELMA study, eight PFAS were measured at median 10 gestational weeks and cases of preeclampsia were postnatally identified from registers. Associations between individual PFAS and preeclampsia were assessed, adjusting for parity, age, weight and smoking. Out of 1,773 women in the study group, 64 (3.6%), developed preeclampsia. A doubling of PFOS and PFNA exposure, corresponding to an inter-quartile increase, was associated with an increased risk for preeclampsia of about 38\u201353% respectively. Serum PFOS within the highest quartile was associated with an odds ratio of 2.68 (CI 95%: 1.17\u20136.12), equal to the increased risk associated with nulliparity, when compared to exposure in the first quartile. The same associations were identified, although with higher risk estimates, in analyses restricted to nulliparous women. For other PFAS, there were no associations. In conclusion and consistent with limited previous research only on PFOS, increasing serum levels of PFOS and PFNA during early pregnancy were associated with a clinically relevant risk of preeclampsia, adjusting for established confounders.<\/jats:p>","DOI":"10.1038\/s41598-019-45483-7","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T10:03:22Z","timestamp":1561370602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in Swedish women"],"prefix":"10.1038","volume":"9","author":[{"given":"Sverre","family":"Wikstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Lindh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl-Gustaf","family":"Bornehag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,24]]},"reference":[{"key":"45483_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","volume":"33","author":"L Duley","year":"2009","unstructured":"Duley, L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 33, 130\u2013137, https:\/\/doi.org\/10.1053\/j.semperi.2009.02.010 (2009).","journal-title":"Semin Perinatol"},{"key":"45483_CR2","unstructured":"Organization., W. H. The World health report: 2005: make every mother and child count. Geneva, Switzerland (2005)."},{"key":"45483_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(10)60279-6","volume":"376","author":"EA Steegers","year":"2010","unstructured":"Steegers, E. A., von Dadelszen, P., Duvekot, J. J. & Pijnenborg, R. Pre-eclampsia. Lancet 376, 631\u2013644, https:\/\/doi.org\/10.1016\/S0140-6736(10)60279-6 (2010).","journal-title":"Lancet"},{"key":"45483_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","volume":"357","author":"JM Roberts","year":"2001","unstructured":"Roberts, J. M. & Cooper, D. W. Pathogenesis and genetics of pre-eclampsia. Lancet 357, 53\u201356 (2001).","journal-title":"Lancet"},{"key":"45483_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K Duckitt","year":"2005","unstructured":"Duckitt, K. & Harrington, D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565, https:\/\/doi.org\/10.1136\/bmj.38380.674340.E0 (2005).","journal-title":"BMJ"},{"key":"45483_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40201-016-0256-9","volume":"14","author":"B Eslami","year":"2016","unstructured":"Eslami, B. et al. Association of serum concentrations of persistent organic pollutants (POPs) and risk of pre-eclampsia: a case-control study. J Environ Health Sci Eng 14, 17, https:\/\/doi.org\/10.1186\/s40201-016-0256-9 (2016).","journal-title":"J Environ Health Sci Eng"},{"key":"45483_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/HYPERTENSIONAHA.114.03545","volume":"64","author":"M Pedersen","year":"2014","unstructured":"Pedersen, M. et al. Ambient air pollution and pregnancy-induced hypertensive disorders: a systematic review and meta-analysis. Hypertension 64, 494\u2013500, https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.114.03545 (2014).","journal-title":"Hypertension"},{"key":"45483_CR8","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/02652030500183474","volume":"22","author":"TH Begley","year":"2005","unstructured":"Begley, T. H. et al. Perfluorochemicals: potential sources of and migration from food packaging. Food Addit Contam 22, 1023\u20131031, https:\/\/doi.org\/10.1080\/02652030500183474 (2005).","journal-title":"Food Addit Contam"},{"key":"45483_CR9","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.envint.2010.05.016","volume":"36","author":"LS Haug","year":"2010","unstructured":"Haug, L. S. et al. Diet and particularly seafood are major sources of perfluorinated compounds in humans. Environment international 36, 772\u2013778, https:\/\/doi.org\/10.1016\/j.envint.2010.05.016 (2010).","journal-title":"Environment international"},{"key":"45483_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1080\/19440040903476590","volume":"27","author":"DB Clarke","year":"2010","unstructured":"Clarke, D. B. et al. Dietary intake estimate for perfluorooctanesulphonic acid (PFOS) and other perfluorocompounds (PFCs) in UK retail foods following determination using standard addition LC-MS\/MS. Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 27, 530\u2013545, https:\/\/doi.org\/10.1080\/19440040903476590 (2010).","journal-title":"Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment"},{"key":"45483_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/oemed-2017-104651","volume":"75","author":"Y Li","year":"2018","unstructured":"Li, Y. et al. Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med 75, 46\u201351, https:\/\/doi.org\/10.1136\/oemed-2017-104651 (2018).","journal-title":"Occup Environ Med"},{"key":"45483_CR12","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1289\/ehp.0901827","volume":"118","author":"K Steenland","year":"2010","unstructured":"Steenland, K., Fletcher, T. & Savitz, D. A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environmental health perspectives 118, 1100\u20131108, https:\/\/doi.org\/10.1289\/ehp.0901827 (2010).","journal-title":"Environmental health perspectives"},{"key":"45483_CR13","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1289\/ehp.10598","volume":"115","author":"AM Calafat","year":"2007","unstructured":"Calafat, A. M., Wong, L. Y., Kuklenyik, Z., Reidy, J. A. & Needham, L. L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115, 1596\u20131602 (2007).","journal-title":"Environ Health Perspect"},{"issue":"5","key":"45483_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/ijerph15050989","volume":"15","author":"Meng-Shan Tsai","year":"2018","unstructured":"Tsai, M. S. et al. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children\u2019s Health. Int J Environ Res Public Health 15, https:\/\/doi.org\/10.3390\/ijerph15050989 (2018).","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"45483_CR15","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1289\/ehp.1510046","volume":"124","author":"CC Bach","year":"2016","unstructured":"Bach, C. C. et al. Perfluoroalkyl Acids in Maternal Serum and Indices of Fetal Growth: The Aarhus Birth Cohort. Environ Health Perspect 124, 848\u2013854, https:\/\/doi.org\/10.1289\/ehp.1510046 (2016).","journal-title":"Environ Health Perspect"},{"key":"45483_CR16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1289\/ehp.1307893","volume":"122","author":"PI Johnson","year":"2014","unstructured":"Johnson, P. I. et al. The Navigation Guide - evidence-based medicine meets environmental health: systematic review of human evidence for PFOA effects on fetal growth. Environ Health Perspect 122, 1028\u20131039, https:\/\/doi.org\/10.1289\/ehp.1307893 (2014).","journal-title":"Environ Health Perspect"},{"key":"45483_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1080\/10408444.2016.1271972","volume":"47","author":"E Negri","year":"2017","unstructured":"Negri, E. et al. Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data. Crit Rev Toxicol 47, 482\u2013508, https:\/\/doi.org\/10.1080\/10408444.2016.1271972 (2017).","journal-title":"Crit Rev Toxicol"},{"key":"45483_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/EDE.0000000000000903","volume":"29","author":"K Steenland","year":"2018","unstructured":"Steenland, K., Barry, V. & Savitz, D. Serum Perfluorooctanoic Acid and Birthweight: An Updated Meta-analysis With Bias Analysis. Epidemiology 29, 765\u2013776, https:\/\/doi.org\/10.1097\/EDE.0000000000000903 (2018).","journal-title":"Epidemiology"},{"key":"45483_CR19","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/10408444.2016.1182117","volume":"46","author":"CC Bach","year":"2016","unstructured":"Bach, C. C. et al. Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review. Crit Rev Toxicol 46, 735\u2013755, https:\/\/doi.org\/10.1080\/10408444.2016.1182117 (2016).","journal-title":"Crit Rev Toxicol"},{"key":"45483_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/humrep\/deu350","volume":"30","author":"MP Velez","year":"2015","unstructured":"Velez, M. P., Arbuckle, T. E. & Fraser, W. D. Maternal exposure to perfluorinated chemicals and reduced fecundity: the MIREC study. Human reproduction 30, 701\u2013709, https:\/\/doi.org\/10.1093\/humrep\/deu350 (2015).","journal-title":"Human reproduction"},{"key":"45483_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3109\/1547691X.2012.755580","volume":"10","author":"B Granum","year":"2013","unstructured":"Granum, B. et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. Journal of immunotoxicology 10, 373\u2013379, https:\/\/doi.org\/10.3109\/1547691X.2012.755580 (2013).","journal-title":"Journal of immunotoxicology"},{"key":"45483_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/EDE.0b013e31824cb93b","volume":"23","author":"DA Savitz","year":"2012","unstructured":"Savitz, D. A. et al. Perfluorooctanoic acid exposure and pregnancy outcome in a highly exposed community. Epidemiology 23, 386\u2013392, https:\/\/doi.org\/10.1097\/EDE.0b013e31824cb93b (2012).","journal-title":"Epidemiology"},{"key":"45483_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/aje\/kwp212","volume":"170","author":"CR Stein","year":"2009","unstructured":"Stein, C. R., Savitz, D. A. & Dougan, M. Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome. Am J Epidemiol 170, 837\u2013846, https:\/\/doi.org\/10.1093\/aje\/kwp212 (2009).","journal-title":"Am J Epidemiol"},{"key":"45483_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/aje\/kwt432","volume":"179","author":"AP Starling","year":"2014","unstructured":"Starling, A. P. et al. Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study. Am J Epidemiol 179, 824\u2013833, https:\/\/doi.org\/10.1093\/aje\/kwt432 (2014).","journal-title":"Am J Epidemiol"},{"key":"45483_CR25","doi-asserted-by":"publisher","first-page":"e000101","DOI":"10.1136\/bmjopen-2011-000101","volume":"1","author":"CL Roberts","year":"2011","unstructured":"Roberts, C. L. et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open 1, e000101, https:\/\/doi.org\/10.1136\/bmjopen-2011-000101 (2011).","journal-title":"BMJ Open"},{"key":"45483_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ajh.2008.20","volume":"21","author":"AB Wallis","year":"2008","unstructured":"Wallis, A. B., Saftlas, A. F., Hsia, J. & Atrash, H. K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens 21, 521\u2013526, https:\/\/doi.org\/10.1038\/ajh.2008.20 (2008).","journal-title":"Am J Hypertens"},{"key":"45483_CR27","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1365-3016.2012.01260.x","volume":"26","author":"K Klungsoyr","year":"2012","unstructured":"Klungsoyr, K., Morken, N. H., Irgens, L., Vollset, S. E. & Skjaerven, R. Secular trends in the epidemiology of pre-eclampsia throughout 40 years in Norway: prevalence, risk factors and perinatal survival. Paediatr Perinat Epidemiol 26, 190\u2013198, https:\/\/doi.org\/10.1111\/j.1365-3016.2012.01260.x (2012).","journal-title":"Paediatr Perinat Epidemiol"},{"key":"45483_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/EDE.0000000000000555","volume":"28","author":"M Pedersen","year":"2017","unstructured":"Pedersen, M. et al. Impact of Road Traffic Pollution on Pre-eclampsia and Pregnancy-induced Hypertensive Disorders. Epidemiology 28, 99\u2013106, https:\/\/doi.org\/10.1097\/EDE.0000000000000555 (2017).","journal-title":"Epidemiology"},{"key":"45483_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/15287391003689317","volume":"73","author":"Y Qian","year":"2010","unstructured":"Qian, Y. et al. Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: role in endothelial permeability. J Toxicol Environ Health A 73, 819\u2013836, https:\/\/doi.org\/10.1080\/15287391003689317 (2010).","journal-title":"J Toxicol Environ Health A"},{"key":"45483_CR30","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0192623311428473","volume":"40","author":"JC DeWitt","year":"2012","unstructured":"DeWitt, J. C., Peden-Adams, M. M., Keller, J. M. & Germolec, D. R. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol 40, 300\u2013311, https:\/\/doi.org\/10.1177\/0192623311428473 (2012).","journal-title":"Toxicol Pathol"},{"key":"45483_CR31","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1161\/CIR.0b013e3181dbece1","volume":"121","author":"RD Brook","year":"2010","unstructured":"Brook, R. D. et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 121, 2331\u20132378, https:\/\/doi.org\/10.1161\/CIR.0b013e3181dbece1 (2010).","journal-title":"Circulation"},{"key":"45483_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1289\/ehp.1408837","volume":"123","author":"MA Verner","year":"2015","unstructured":"Verner, M. A. et al. Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK). Environ Health Perspect 123, 1317\u20131324, https:\/\/doi.org\/10.1289\/ehp.1408837 (2015).","journal-title":"Environ Health Perspect"},{"key":"45483_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-3016.2012.01314.x","volume":"26","author":"CG Bornehag","year":"2012","unstructured":"Bornehag, C. G. et al. The SELMA study: a birth cohort study in Sweden following more than 2000 mother-child pairs. Paediatr Perinat Epidemiol 26, 456\u2013467, https:\/\/doi.org\/10.1111\/j.1365-3016.2012.01314.x (2012).","journal-title":"Paediatr Perinat Epidemiol"},{"key":"45483_CR34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.chemosphere.2012.03.049","volume":"88","author":"CH Lindh","year":"2012","unstructured":"Lindh, C. H. et al. Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations. Chemosphere 88, 1269\u20131275, https:\/\/doi.org\/10.1016\/j.chemosphere.2012.03.049 (2012).","journal-title":"Chemosphere"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45483-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T10:46:46Z","timestamp":1671274006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45483-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,24]]},"assertion":[{"value":"9 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9179"}}